Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481-Reference-Cited by-同舟云学术

Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481

Published:2019-02-17 Issue:3 Volume:10 Page:312-317
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Boy Kenneth M.¹^ORCID,Guernon Jason M.¹,Zuev Dmitry S.¹,Xu Li¹,Zhang Yunhui¹,Shi Jianliang¹,Marcin Lawrence R.¹^ORCID,Higgins Mendi A.¹,Wu Yong-Jin¹^ORCID,Krishnananthan Subramaniam¹,Li Jianqing¹^ORCID,Trehan Ashok¹,Smith Daniel¹,Toyn Jeremy H.¹,Meredith Jere E.¹,Burton Catherine R.¹,Kimura S. Roy¹,Zvyaga Tatyana¹,Zhuo Xiaoliang¹,Lentz Kimberley A.¹,Grace James E.¹,Denton Rex¹,Morrison John S.¹,Mathur Arvind²,Albright Charles F.¹,Ahlijanian Michael K.¹,Olson Richard E.¹,Thompson Lorin A.¹,Macor John E.¹

Affiliation:

1. Bristol-Myers Squibb, Wallingford, Connecticut 06492, United States

2. Bristol-Myers Squibb, Princeton, New Jersey 08543, United States

Funder

Bristol-Myers Squibb

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.8b00541

Reference28 articles.

1. 2018 Alzheimer's disease facts and figures

2. Merck press release, February 13, 2018. http://investors.merck.com/news/press-release-details/2018/Merck-Announces-Discontinuation-of-APECS-Study-Evaluating-Verubecestat-MK-8931-for-the-Treatment-of-People-with-Prodromal-Alzheimers-Disease/default.aspx, (accessed August 1, 2018).

3. BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

4. Lilly/Astra-Zeneca press release, June 12, 2018. https://www.astrazeneca.com/media-centre/press-releases/2018/update-on-phase-iii-clinical-trials-of-lanabecestat-for-alzheimers-disease-12062018.html, (accessed August 1, 2018).

5. The Many Substrates of Presenilin/γ-Secretase

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P,N‐Coordinating Ylide‐Functionalized Phosphines (NYPhos): A Ligand Platform for the Selective Monoarylation of Small Nucleophiles;Angewandte Chemie International Edition;2024-08-02

2. P,N‐koordinierende Ylid‐funktionalisierte Phosphane (NYPhos): Eine Ligandenplattform für die selektive Monoarylierung kleiner Nukleophile;Angewandte Chemie;2024-08-02

3. Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease;Journal of Medicinal Chemistry;2024-06-07

4. Review of triazole scaffolds for treatment and diagnosis of Alzheimer's disease;Chemico-Biological Interactions;2023-09

5. Mechanistic investigation of liver injury induced by BMS-932481, an experimental ɣ-secretase modulator;Toxicological Sciences;2023-06-01